Development of universal influenza vaccines based on influenza virus M and NP genes

Efficacy of Parainfluenza Virus 5 Mutants Expressing Hemagglutinin from H5N1 Influenza A Virus in Mice

(2013) Z. Li et al.   JOURNAL OF VIROLOGY

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

(2012) Patrick J. Lillie et al.   CLINICAL INFECTIOUS DISEASES

Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

(2012) Jacob Atsmon et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine

(2012) Aseem Pandey et al.   PLoS One

A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years

(2012) Richard D. Antrobus et al.   PLoS One

Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli

(2012) Wenling Wang et al.   PLoS One

Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus

(2012) Amy C. Boyd et al.   VACCINE

A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus

(2011) Alan G. Goodman et al.   PLoS One

Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults

(2011) Christine B. Turley et al.   VACCINE

Broad Humoral and Cellular Immunity Elicited by a Bivalent DNA Vaccine Encoding HA and NP Genes from an H5N1 Virus

(2011) Ke Xu et al.   VIRAL IMMUNOLOGY

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

(2010) Zhiwei Sui et al.   ARCHIVES OF VIROLOGY

Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein

(2010) Lina Guo et al.   ARCHIVES OF VIROLOGY

Multimeric-001: BiondVax’s universal flu vaccine

(2010) Tamar Ben-Yedidia   Expert Review of Vaccines

A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge

(2010) Dongming Zhou et al.   MOLECULAR THERAPY

Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin

(2010) H. Keipp Talbot et al.   PLoS One

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

(2010) Zhiwei Sui et al.   VACCINE

Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype

(2010) Keith Ameiss et al.   VACCINE

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant

(2010) Guangyu Zhao et al.   VACCINE

Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults

(2010) John J. Treanor et al.   VACCINE

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

(2010) Guangyu Zhao et al.   Virology Journal

Pandemic preparedness: Toward a universal influenza vaccine

(2009) K. Roose et al.   DRUG NEWS & PERSPECTIVES

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments

(2009) Michael Schotsaert et al.   Expert Review of Vaccines

A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine

(2009) Arvydas Ambrozaitis et al.   VACCINE

M2e-based universal influenza A vaccine

(2009) Walter Fiers et al.   VACCINE

Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route

(2009) Guo-guang Zhang et al.   VETERINARY RESEARCH COMMUNICATIONS

The influenza matrix protein 2 as a vaccine target

(2008) Xavier Saelens   Future Virology

An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2

(2008) Marina De Filette et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs

(2008) Langzhou Song et al.   PLoS One

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies

(2008) Chia-Yun Lo et al.   VACCINE

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform

(2008) Jérôme Denis et al.   VACCINE

CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine

(2008) Dubravka Grdic Eliasson et al.   VACCINE

Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus

(2008) Quanjiao Chen et al.   VIRUS GENES

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

(2007) Juliana Bessa et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

(2007) James W. Huleatt et al.   VACCINE